Table 5– Performance of the prediction model in bakers with low scores with and without sensitisation to wheat or α-amylase
NonsensitisedSensitisedTotal
Bakers318 (87.1)47 (12.9)365 (100.0)#
Age yrs41.5±11.441.6±9.241.5±11.2
Working time yrs16.4±11.915.7±11.216.3±11.8
Questionnaire responses
 Wheezing in last 12 months9 (2.9)1 (2.2)10 (2.8)
 Wheezing that improves if not working1 (0.3)0 (0.0)1 (0.3)
 Eye symptoms that improve if not working4 (1.3)0 (0.0)4 (1.1)
 Running nose/sneezing that improves if not working13 (4.1)0 (0.0)13 (3.6)
Use of medication for asthma in last 12 months3 (1.0)3 (6.4)6 (1.6)
 Inhalation corticosteroids plus long-acting β2-mimetics3 (1.0)2 (4.7)5 (1.4)
 Short-acting β2-mimetics2 (0.7)3 (7.0)5 (1.4)
  • Data are presented as n (%) or mean±sd. #: 372 individuals had low scores; no blood was drawn from seven of these individuals.